The recent news for Zimmer Biomet Holdings (ZBH) encompass a wide range of topics, including dividends, conference appearances, and financial outcomes. ZBH has confirmed its quarterly dividend of $0.24 and revealed its presence at the 27th Annual Barclays Healthcare Conference. Additionally, Jehanzeb Noor is the newly appointed Senior Vice President, Chief Strategy, Innovation, and Business Development Officer. The company experienced strong revenue growth noted in their Q4 2024 Earnings Call.
A new marketing campaign with Arnold Schwarzenegger targeting joint pain has been launched. Leadership adjustments resulted in Ivan Tornos being the new board chair and a $0.24 dividend announcement. Additionally, ZBH is set to acquire Paragon 28, strengthening its position in the market. However, the company also reported a below-estimated profit forecast for 2025, and a disappointing stock outlook. Wall Street analysts appear split on predicting ZBH's stock performance.
The introduction of Arnold Schwarzenegger as Chief Movement Officer will likely garner public interest. FDA clearance for new medical devices like the OsseoFit™ Stemless Shoulder System and Oxford® Cementless Partial Knee promises potential growth.
Zimmer Biomet Holdings ZBH News Analytics from Thu, 02 May 2024 07:00:00 GMT to Sat, 01 Mar 2025 13:51:59 GMT - Rating 3 - Innovation 6 - Information 8 - Rumor -3
